5 Young Innovators Transforming the Future of Biotech
- According to reporting published by MIT Technology Review, the publication released its annual selection of 35 Innovators Under 35, highlighting nine emerging leaders who are transforming the field...
- Among the honorees is Paschal Kija, a 28-year-old who developed a specialized medical device to treat postpartum hemorrhage, a severe birth complication that accounts for approximately 29 percent...
- To address the tissue damage often caused by traditional rigid brain electrodes, 34-year-old Xiao Yang is designing ultra-small, flexible alternatives that closely mimic the physical structure of actual...
According to reporting published by MIT Technology Review, the publication released its annual selection of 35 Innovators Under 35, highlighting nine emerging leaders who are transforming the field of biotechnology. The roster showcases young scientists and researchers working on diverse technological frontiers, ranging from medical devices designed to prevent maternal mortality to generative artificial intelligence models used for engineering synthetic viruses.
Preventing Maternal Hemorrhage in Tanzania
Among the honorees is Paschal Kija, a 28-year-old who developed a specialized medical device to treat postpartum hemorrhage, a severe birth complication that accounts for approximately 29 percent of maternal deaths in Tanzania. Named the Mkanda Salama—which translates to Safe Wrap in Swahili—the device is engineered to be simple to use while maintaining a low manufacturing cost of $70, according to verified reporting. Data from a study cited in the reports indicate that the device successfully halted postpartum bleeding in 73 percent of treated women within a 20-minute window.
Flexible Brain Electrodes Inspired by Kirigami
To address the tissue damage often caused by traditional rigid brain electrodes, 34-year-old Xiao Yang is designing ultra-small, flexible alternatives that closely mimic the physical structure of actual neurons. In addition to individual microscopic probes, Yang has engineered sheets of electrodes intended for laboratory study of brain cells. Her design draws inspiration from kirigami, the traditional Japanese art of cutting paper to form three-dimensional shapes, resulting in a honeycombed, spiral-basket structure that she currently employs in cellular research.
Personalized Gene-Editing for Infant Treatment
The biotechnology list also recognizes clinical breakthroughs, including the work of 26-year-old Sarah Grandinette. Grandinette served on a team that formulated a customized gene-editing therapy for Kyle “KJ” Muldoon Jr., an infant born in 2024 with a rare and potentially fatal genetic disorder characterized by a specific genetic misspelling. By synthesizing cells carrying the patient’s exact genetic variant, Grandinette screened various gene-editing strategies and tested candidate medicines in animal models including mice and monkeys. The infant received an initial dose of the therapy at approximately seven months of age, showed positive clinical responses, and was subsequently discharged from the hospital. Grandinette stated that the child is doing pretty great,
according to MIT Technology Review.
Cellular Reprogramming and Longevity Research
In the longevity sector, 34-year-old Yuancheng (Ryan) Lu is advancing cellular reprogramming technologies aimed at resetting cells to a more embryonic-like state to combat age-related conditions. Lu and his research colleagues published a 2020 study demonstrating that reprogramming therapy could reverse vision loss in aged, blind mice. Building on those findings, a nearly identical iteration of the therapeutic approach has advanced to human clinical evaluation, with the development company Life Biosciences dosing its first volunteer participant in June, as detailed in the source reports.
Generative AI for Synthetic Bacteriophage Design
Expanding into synthetic biology, 27-year-old Samuel King utilized a generative artificial intelligence model to generate novel genetic blueprints for bacteriophages, which are microscopic viruses that infect bacteria. After generating the sequences, King printed them as physical strands of DNA for laboratory testing. Experimental results showed that the AI-designed viruses successfully replicated, lysed out of bacterial host cells, and infected neighboring bacteria. Although viruses are biologically non-living entities, King aims to adapt AI-designed life forms for future applications such as pharmaceutical manufacturing or environmental remediation, according to the published coverage.
